109 related articles for article (PubMed ID: 15930272)
1. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.
Song L; Zlobin A; Ghoshal P; Zhang Q; Houde C; Weijzen S; Jiang Q; Nacheva E; Yagan D; Davis E; Galiegue-Zouitina S; Catovsky D; Grogan T; Fisher RI; Miele L; Coignet LJ
Cancer Res; 2005 Jun; 65(11):4554-61. PubMed ID: 15930272
[TBL] [Abstract][Full Text] [Related]
2. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex.
Jayne S; Zwartjes CG; van Schaik FM; Timmers HT
Biochem J; 2006 Sep; 398(3):461-7. PubMed ID: 16712523
[TBL] [Abstract][Full Text] [Related]
4. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip J; Montero A
Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
[TBL] [Abstract][Full Text] [Related]
6. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
8. DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes.
Tanaka K; Okamoto S; Ishikawa Y; Tamura H; Hara T
Oncogene; 2009 May; 28(21):2142-51. PubMed ID: 19398953
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes.
Faist F; Short S; Kneale GG; Sharpe CR
Biosci Rep; 2009 Jun; 29(3):143-9. PubMed ID: 18752469
[TBL] [Abstract][Full Text] [Related]
11. Evolution of 8p loss in transformed human prostate epithelial cells.
Macoska JA; Paris P; Collins C; Andaya A; Beheshti B; Chaib H; Kant R; Begley L; MacDonald JW; Squire JA
Cancer Genet Cytogenet; 2004 Oct; 154(1):36-43. PubMed ID: 15381370
[TBL] [Abstract][Full Text] [Related]
12. Transformation in lymphomas--morphological, immunophenotypic and molecular features.
Prochorec-Sobieszek M; Majewski M; Sikorska A; Centkowski P; Tajer J; Lampka-Wojciechowska E; Rymkiewicz G; Konopka L; Meder J; Warzocha K; Maryniak RK
Pol J Pathol; 2006; 57(2):63-70. PubMed ID: 17019967
[TBL] [Abstract][Full Text] [Related]
13. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron.
Jepsen K; Solum D; Zhou T; McEvilly RJ; Kim HJ; Glass CK; Hermanson O; Rosenfeld MG
Nature; 2007 Nov; 450(7168):415-9. PubMed ID: 17928865
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel repressor element in the cyclo-oxygenase-2 promoter and its nuclear binding protein.
Yang X; Lin L; Zhang X; Ji Y; Lv J; Zhu Y; Yin Y; Sun Y; Han X
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1204-8. PubMed ID: 18518878
[TBL] [Abstract][Full Text] [Related]
15. Chromosome band 6q deletion pattern in malignant lymphomas.
Taborelli M; Tibiletti MG; Martin V; Pozzi B; Bertoni F; Capella C
Cancer Genet Cytogenet; 2006 Mar; 165(2):106-13. PubMed ID: 16527604
[TBL] [Abstract][Full Text] [Related]
16. Pinning down HER2-ER crosstalk in SMRT regulation.
Ryo A; Wulf G; Lee TH; Lu KP
Trends Biochem Sci; 2009 Apr; 34(4):162-5. PubMed ID: 19269830
[TBL] [Abstract][Full Text] [Related]
17. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.
Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
Cancer Res; 2006 Sep; 66(18):9125-33. PubMed ID: 16982755
[TBL] [Abstract][Full Text] [Related]
19. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
[TBL] [Abstract][Full Text] [Related]
20. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
Yu DH; Fan W; Liu G; Nguy V; Chatterton JE; Long S; Ke N; Meyhack B; Bruengger A; Brachat A; Wong-Staal F; Li QX
Exp Cell Res; 2006 Apr; 312(6):865-76. PubMed ID: 16413018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
